Quoin Pharmaceuticals (2EB0) Q3 2020 Earnings Report
DE:2EB0 Q3 2020 EPS Results
- Actual EPS
- -EUR 0.44
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 2.17
DE:2EB0 Q3 2020 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2020
- Date
- 11/18/2020
- Time
- Before Open
- Conference Call
- Wednesday, November 18, 2020
DE:2EB0 Upcoming Earnings
Quoin Pharmaceuticals's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q3 2020 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2020 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2020 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2EB0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -1.35- | -5.99 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | -1.44-1.70 | -5.6 | 69.75% (+3.91) | |
| May 07, 2026 | 2026 (Q1) | -1.94-1.58 | -5.8 | 72.77% (+4.22) | |
| Mar 26, 2026 | 2025 (Q4) | -3.59-1.55 | -10.93 | 85.80% (+9.38) | |
| Nov 06, 2025 | 2025 (Q3) | -3.82-5.99 | -14.68 | 59.21% (+8.69) | |
| Aug 07, 2025 | 2025 (Q2) | -6.09-5.60 | -12.18 | 53.99% (+6.58) | |
| May 13, 2025 | 2025 (Q1) | -6.40-5.80 | -34.67 | 83.27% (+28.87) | |
| Mar 13, 2025 | 2024 (Q4) | -14.37-10.93 | -64.97 | 83.17% (+54.04) | |
| Nov 07, 2024 | 2024 (Q3) | -13.74-14.68 | -60.91 | 75.90% (+46.23) | |
| Aug 08, 2024 | 2024 (Q2) | -19.60-12.18 | -66.53 | 81.69% (+54.35) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed